The CDC and FDA lifted their pause on the Johnson & Johnson Covid vaccine, following the recommendation of a group of CDC advisers
The US Centers for Disease Control and Prevention and Food and Drug Administration lifted their recommended pause on use of Johnson & Johnson's coronavirus vaccine Friday and said the label will be updated to warn of blood clot risks.
The agencies acted quickly after a vote by the CDC's Advisory Committee for Immunization Practices recommended lifting the pause. | | | | | | | |